Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

A

AMRN

Amarin Corporation plc

NASDAQHealthcareBiotechnologyIE

NASDAQ · Healthcare · Biotechnology · IE

$13.63

−0.58%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

AMRN: FY25 Deep Dive

Amarin Corp FY25 at $183M. NI $-39M; EPS $-0.09.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.